Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a promising ...

Katie Price has given an update on her son Harvey's health, revealing he is embarking on a new medical journey.

Sharing the news in a recent podcast episode, Katie Price explained that a "lot's gonna change" for her son, Harvey, who is ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Joie Armstrong asked her doctor about taking a GLP-1 medication to help her lose weight six times before she got a prescription, and then was denied coverage by her insurance company. Adrian, a ...

Katie Price has shared that her son Harvey will undergo a new medical regimen that is set to transform his appearance.

Two growth stocks in the healthcare industry stand out in particular. Here is what you need to know about each one and why ...

Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ethical issues and prices that are still too high for many patients.

How does Innovent Biologics' mazdutide, a groundbreaking dual GLP-1/glucagon receptor drug just approved in China, compared to Wegovy and Zepbound? Read more here.

Opening up in a recent podcast episode, Katie Price disclosed that a "lot's gonna change" for her son, Harvey, who is set to move from college to "independent living" ...

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...